drugset / Trial / NCT03230474

a Small Dose of Naloxone,Minimize Intrathecal Morphine Side Effects

NCT03230474

Completed 100 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

I.V naloxone decreases incidence and severity of the common morphine side effects (pruritis, nausea/emesis, constipation, urinary retention, respiratory depression and undesirable sedation) so using it as additive to intrathecal morphine in patients undergoing anal surgeries under spinal anesthesia may be beneficail

Timeline

Start
2016-05
Primary completion
2017-02
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naloxone Small molecule 5 ng
Background Bupivacaine Other / unclassified 5 mg
Comparator Morphine Other / unclassified 0.2 mg Intrathecal

Indications

No indication recorded.